ArticleJournal of clinical medicine2026

Evaluation of the Efficacy of Semaglutide Dose Escalation in Reducing HbA1c Levels and Insulin Dose in Type 2 Diabetes Patients: Real-World Semaglutide Data from Türkiye, SEMA-TR Study.

Hilmi Erdem Sumbul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.